Superior vena caval stenting for SVC obstruction: Current status

Ganeshan, Arul; Hon, Lye Quen; Warakaulle, Dinuke; Morgan, Robert; Uberoi, Raman

doi:10.1016/j.ejrad.2008.04.014

Cited by 80 publications

(46 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In cases of bilateral brachiocephalic vein thrombosis, restoring flow in one vein is usually sufficient to relieve symptoms on both sides. [4,5] This is likely explained by the fact that the collaterals would cross the midline and drain the contralateral vein. Cannulation of both veins is not only time-consuming but is also technically difficult and not cost effective.…”

Section: Discussionmentioning

confidence: 99%

“…[3, 4,5,6] Currently, no large clinical trials comparing antiplatelet agents vs. anticoagulants after SVC stenting are underway.…”

Section: Discussionmentioning

confidence: 99%

“…[3, 4,5] Stenting gives a favorable long-term effect if anticoagulation is effective. While there is no consensus in the literature regarding the effectiveness of anticoagulation therapy in preventing SVC stent thrombosis, anticoagulants or anti-platelet agents are generally prescribed for a period of 1-9 months postoperatively.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Successful removal of stented leads by using percutaneous approach

Jonik¹,

Grabowski²,

Pietura³

et al. 2017

Heart Beat

View full text Add to dashboard Cite

Background: Nowadays we are implanting more cardiac implantable electronic device (CIED) systems with intracardiac leads. Unfortunately, sometimes when the lead remains in the vessel too long it adheres to its wall, causing venous occlusion, and the removal is problematic. Venous occlusion is treated with venoplasty with the stent remaining. The standards clearly recommend removing all leads before venoplasty and stenting. Stenting of leads into the vessel wall makes them practically indelible. In the literature, we found only one report of successful removal of veno-thoracic stented leads.

show abstract

Section: Discussionmentioning

confidence: 99%

“…[3, 4,5,6] Currently, no large clinical trials comparing antiplatelet agents vs. anticoagulants after SVC stenting are underway.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Successful removal of stented leads by using percutaneous approach

Jonik¹,

Grabowski²,

Pietura³

et al. 2017

Heart Beat

View full text Add to dashboard Cite

show abstract

“…These range from minor complications, such as access site hematoma, epistaxis, and chest pain, to major ones, such as pulmonary embolus, cardiac tamponade, stent migration, and thoracic hemorrhage. 25 Flash pulmonary edema from the sudden restoration of robust venous return to an underfilled right heart has also been reported albeit rare.…”

Section: Superior Vena Cava Syndromementioning

confidence: 99%

Venous Interventions

O'Dea

Schainfeld

2014

Circ: Cardiovascular Interventions

View full text Add to dashboard Cite

These studies indicate that CDT for DVT achieves more rapid lysis, reduces the incidence of long-term sequelae of DVT, improves quality of life, preserves valvular competence and more completely restores vessel patency as compared with standard anticoagulation or systemic thrombolytic therapy, although at the expense of a higher rate of hemorrhagic complications (see Table 1 summary of CDT trials).

show abstract

“…Headache is a common symptom and it is usually continuous and pressing, exacerbated by coughing. Epilepsy has been occasionally reported as well as psychosis, probably due to carbon dioxide accumulation [3,4,[7][8][9][10][11][12][13][14]. Dyspnea can be directly related to the mediastinal mass or be caused by pleural effusion or cardiocirculatory impairment.…”

Section: Clinical Presentationmentioning

confidence: 99%